loading page

Optical evaluation of immunocomplex of liquid crystal bound amyloid beta-42 levels associated with Alzheimer's disease
  • Emine Kemiklioglu,
  • Ebru Aygan,
  • Gonen Ozsarlak Sozer
Emine Kemiklioglu
Manisa Celal Bayar University

Corresponding Author:emine.kemiklioglu@cbu.edu.tr

Author Profile
Ebru Aygan
Ege University
Author Profile
Gonen Ozsarlak Sozer
Ege University
Author Profile


We present an optical biosensor in this study which is based on the LC orientation as a function of the peptide concentration to detect amyloid-beta-42 (Aβ42) antigen-antibody binding events. These binding of Aβ42 peptide to an Aβ42 antibody which is on a Dimethyloctadecyl[3-(trimethoxysilyl)propyl] ammonium chloride (DMOAP) occurs on an immobilized surface forming an immunocomplex. The disturbed orientation of LCs as a result of the binding of the formed immunocomplex observed using the polarized optical microscope. The microscopic and optical response of the LC-immunocomplex was determined as a function of decreasing Aβ42 peptide concentration. Aβ42 peptide concentrations as of 1000 pg/ml, 500 pg/ml, 200 pg/ml, 100 pg/ml, 50 pg/ml, 25 pg/ml, 20 pg/ml, 15 pg/ml, 10 pg/ml, 5 pg/ml, and 1 pg/ml, respectively were interacted with the optimum Aβ42 antibody concentration as of 25 µg/ml. There was a remarkable change in the reflection spectra of the samples with the decreasing Aβ42 peptide concentration. The concentration as low as 1 pg/ml of Aβ42 peptide was able to successfully detected in our system.